Platform Features
Platform Features
Features
Investment Products
Private Wealth Management
Trading Tools
Market Data Services
Analysis Tools
News Services
For Developers
Account Types
For Individuals
For Institutions
Café
More
Log in / Sign up
Abbvie
ABBV
--
--
Start trading
Overview
Overview
News
News
Posts
Posts
Financials
Financials
Forecast
Forecast
Valuation
Valuation
Shareholders
Shareholders
Profile
Profile
Weekly Review
Weekly Review
All
24/7
Ratings
All
24/7
Ratings
Weekly Recap | Abbvie +0.26%, most brokers rate it buy
Weekly Review
·
Sep 12 at 07:40 AM
ABBV
+0.58%
Weekly Recap | Abbvie +0.38%, positive Phase 3 myeloma data
Weekly Review
·
Sep 5 at 06:00 AM
ABBV
+0.58%
Weekly Recap | Abbvie -3.58%, most brokers rate it buy
Weekly Review
·
Aug 29 at 05:11 AM
ABBV
+0.58%
Weekly Recap | Abbvie +6.21%, closing in on record highs
Weekly Review
·
Aug 22 at 06:53 AM
ABBV
+0.58%
